Surgery Wound Management: Healing, Sutures, and Complications
Wound Healing Phases · Flap Design · Suture Materials · Complications · Dry Socket
TL;DR
Surgical wound management encompasses the principles of wound healing biology, flap design, suture material selection, wound closure technique, and the recognition and management of post-operative complications. Understanding wound healing is fundamental to all surgical disciplines in dentistry — from simple tooth extractions to complex orthognathic and reconstructive procedures. The four sequential but overlapping phases of wound healing (haemostasis, inflammation, proliferation, remodelling) provide the biological framework for every clinical decision in wound management.
- The four phases of wound healing — haemostasis (0–3 days), inflammation (0–5 days), proliferation (3 days–3 weeks), and remodelling/maturation (3 weeks–2 years) — are sequential but overlapping, and any disruption of one phase impairs all subsequent phases: During haemostasis, platelet aggregation and the coagulation cascade form a fibrin clot that provides both haemostasis and a provisional scaffold for subsequent cellular migration. The platelet α-granules release PDGF (platelet-derived growth factor), TGF-β, and VEGF to initiate the subsequent phases. During the inflammatory phase, neutrophils (polymorphonuclear leucocytes — PMNs) arrive first (within hours) via diapedesis from capillaries responding to chemokines and complement activation; they perform bacterial phagocytosis and release proteases to debride the wound. From day 2–3, macrophages replace neutrophils as the predominant inflammatory cell — macrophages are the orchestrators of healing, performing phagocytosis of debris and apoptotic neutrophils, and secreting cytokines and growth factors (IL-1, TNF-α, IL-6, TGF-β, FGF, PDGF) that recruit and activate fibroblasts and endothelial cells for the proliferative phase. During proliferation (days 3–21), fibroblasts migrate into the wound and synthesise collagen (predominantly type III — immature, weaker than type I); angiogenesis (VEGF-driven formation of new capillaries); and epithelialisation (keratinocyte migration from wound edges — no mitosis at the leading edge — contact inhibition of locomotion). Granulation tissue (fibroblasts + macrophages + new capillaries in a collagen-I/III matrix) fills the wound defect. During remodelling (weeks 3 to up to 2 years), collagen type III is progressively replaced by collagen type I (stronger, better organised, cross-linked); myofibroblast-mediated wound contraction reduces wound size; and scar tensile strength increases but reaches a maximum of only 80% of unwounded tissue — wounds NEVER fully regain pre-injury tensile strength.
- Dry socket (alveolar osteitis) is the most common post-extraction complication — it occurs on days 2–4 when the blood clot is lost or fails to organise, exposing bare bone; it is NOT an infection and antibiotics are NOT first-line treatment: Dry socket (alveolar osteitis) affects approximately 2–5% of simple extractions and up to 20–30% of mandibular third molar extractions. Risk factors: smoking (vasoconstriction impairs clot formation; sucking motion dislodges clot; nicotine and cotinine impair neutrophil function); oral contraceptives (oestrogen activates fibrinolytic cascade); traumatic extraction; pre-existing pericoronitis/infection; poor oral hygiene; inadequate irrigation of socket post-extraction; female sex; posterior mandible site. Pathophysiology: the blood clot either fails to form adequately, is mechanically dislodged (by suction, spitting, vigorous rinsing), or is dissolved prematurely by fibrinolysis (activated by bacteria or oestrogen). The exposed bare bone (alveolar bone and cortical plate) has no protective clot and no epithelial cover — it is supplied by sensory nerves (inferior alveolar nerve branches) that fire continuously in response to chemical irritation by food debris and bacteria. Diagnosis: empty socket (absent or degenerated clot) ± food debris; halitosis; severe, persistent, throbbing pain typically beginning days 2–4 after extraction (too late for normal post-op pain); pain radiating to ear and temple (via auriculotemporal nerve); no fluctuance, no pus, no significant erythema (distinguishing from infection/abscess). Management: gentle irrigation of socket with normal saline or chlorhexidine 0.12% to remove debris; pack socket with medicated dressing — ZOE-eugenol paste (Alvogyl) or bismuth iodoform paraffin paste (BIPP); eugenol provides local anaesthesia by suppressing C-fibre activity; change dressing every 3–5 days until pain resolves; analgesics (NSAIDs + paracetamol ± codeine); secondary epithelialisation from socket walls proceeds under the dressing; do NOT curettage socket aggressively (removes granulation tissue). Antibiotics: NOT indicated for uncomplicated dry socket — it is not a bacterial infection but a failure of clot organisation; antibiotics do not speed healing and add side effects. Antibiotics are indicated only if there are signs of osteomyelitis (spreading cellulitis, constitutional symptoms, persistent bone exposure beyond 2–3 weeks despite treatment).
- Suture material selection is based on the principle of choosing the least reactive, appropriately absorbable material for the tissue being closed — the ideal suture provides adequate tensile strength for the duration of healing, then dissolves without foreign body reaction: Sutures are classified as absorbable (natural or synthetic) or non-absorbable. Absorbable sutures degrade by hydrolysis (synthetic — Vicryl, Monocryl, PDS) or enzymatic proteolysis (natural gut — plain gut, chromic gut). Synthetic absorbable sutures are preferred over natural gut in oral surgery because they maintain predictable tensile strength, lose strength at a defined rate, and elicit less inflammation than gut (which triggers macrophage proteolytic digestion). Vicryl (polyglactin 910): most commonly used absorbable suture in oral surgery; 75% tensile strength at 2 weeks; complete absorption at 60–90 days; braided (more tissue drag; slight bacterial harbourage risk). Monocryl (poliglecaprone 25): monofilament; superior handling; minimal tissue drag; 50–60% strength at 1 week; complete absorption at 90–120 days; preferred for skin closure. PDS (polydioxanone): monofilament; longest-lasting absorbable (50% strength at 4 weeks; complete absorption at 180–210 days); used for deep fascial layers and tendons where prolonged support is needed. Non-absorbable sutures in oral surgery: silk (natural; relatively biocompatible but wicks bacteria; not truly non-absorbable — absorbed over years; most comfortable intraorally; preferred by many surgeons for mucosal closure); nylon (Ethilon/Prolene — monofilament; minimal tissue reactivity; used for skin; requires removal at 5–7 days on face); PTFE (Gore-Tex — monofilament; minimal reactivity; used in guided bone/tissue regeneration). Suture gauge: 3-0 for oral mucosa (standard extraction); 4-0 for facial skin and precise mucosal closure; 5-0/6-0 for microsurgery and delicate facial skin.
- Flap design in oral surgery must respect the vascular supply — the base of the flap must always be wider than the apex, releasing incisions must not cross bony prominences, and full-thickness (mucoperiosteal) elevation protects the periosteum and its bone-forming capacity: A mucoperiosteal flap consists of oral mucosa, submucosa, and periosteum elevated as a single full-thickness layer. The periosteum contains osteoprogenitor cells and is the primary source of bone repair — damaging or excessively stripping the periosteum impairs post-operative bone healing and increases the risk of bone sequestration. Flap design principles: (1) The base must be wider than the apex (base:apex ratio ≥1:1 for mucoperiosteal flaps) to ensure adequate blood supply from the submucosal plexus enters the base of the flap; narrow-based flaps undergo ischaemia and necrosis at their apex. (2) Releasing incisions should be vertical (perpendicular to the gingival margin) and placed over solid bone (not over the surgical defect) — this ensures the closure line has bony support beneath it and reduces dehiscence risk. (3) Avoid mental foramen (anterior to first premolar, inferior): releasing incisions should be placed anterior to the mental foramen area or posterior — a transected mental nerve causes permanent labial and chin numbness. (4) Common flap designs: envelope (horizontal crestal incision only — adequate for simple extractions); triangular (envelope + one vertical releasing incision); trapezoidal/rectangular (envelope + two vertical releasing incisions — maximum exposure for complex procedures). (5) The flap should provide adequate access to the underlying surgical site without undue tissue retraction — excessive tension causes ischaemia and necrosis at wound margins.
- The most important systemic factor impairing wound healing is diabetes mellitus — hyperglycaemia impairs every phase of wound healing via neutrophil dysfunction, impaired angiogenesis, reduced collagen synthesis, and increased infection risk: Diabetes mellitus (DM) is the single most significant systemic impairment to wound healing and is the most frequently tested in board examinations. Mechanisms: (1) Hyperglycaemia non-enzymatically glycates collagen (AGEs — advanced glycation end-products), making it cross-linked and brittle — impairs remodelling; (2) Impaired neutrophil chemotaxis and phagocytosis — increased susceptibility to infection; (3) Impaired macrophage function — reduced growth factor secretion — impaired fibroblast recruitment and angiogenesis; (4) Impaired fibroblast proliferation and reduced collagen type I synthesis; (5) Reduced VEGF production — impaired angiogenesis — ischaemic wound environment; (6) Peripheral neuropathy — impaired wound sensation — pressure injury goes unnoticed. Clinical implications: HbA1c >8.0% correlates with significantly increased wound infection and dehiscence rates; elective surgery should be delayed until HbA1c <8.0% (ideally <7.0%); peri-operative glucose monitoring; morning appointments (lower cortisol); antibiotic prophylaxis may be considered for complex procedures in poorly controlled DM. Other systemic impairments: malnutrition (vitamin C deficiency — scurvy — impairs proline/lysine hydroxylation in collagen synthesis; zinc deficiency — impairs fibroblast proliferation and DNA synthesis); corticosteroids (suppress inflammation, impair collagen synthesis — increased dehiscence and infection risk; consider steroid cover if HPA suppressed); smoking (vasoconstriction; impaired neutrophil function; CO-haemoglobin reduces tissue oxygenation; nicotine inhibits fibroblast proliferation); radiotherapy (obliterative endarteritis — impairs blood supply; tissue hypoxia; MRONJ risk in irradiated bone); chemotherapy (impairs all rapidly dividing cells — neutropenia increases infection risk, impaired epithelialisation, poor collagen production); renal failure (uraemia — impairs platelet function and collagen synthesis); hepatic failure (impaired clotting factor synthesis — bleeding risk); anaemia (reduced oxygen delivery to wound).
Key Facts
What Is Surgical Wound Management?
Surgical wound management encompasses the complete biological and clinical framework for ensuring optimal healing after a surgical incision or tissue injury. It includes understanding wound healing biology, planning surgical access (flap design), selecting appropriate materials (sutures, dressings, haemostatic agents), executing wound closure, managing post-operative care, and recognising and treating complications when they arise.
In dentistry and oral surgery, wound management principles apply across a broad spectrum — from the socket after a tooth extraction to the flap closed after implant placement, bone grafting, periodontal surgery, orthognathic surgery, and maxillofacial reconstruction. The biological process of wound healing is fundamentally the same across all tissues; what differs is the local environment, blood supply, microbial load, and specific tissue requirements.
Why It Matters for Board Exams
Wound management is a high-yield topic across all dental board examinations because it integrates basic science (histology, biochemistry, microbiology, pharmacology) with clinical application. Examiners consistently test knowledge of wound healing phases and their cellular mediators, suture material properties, flap design rules, dry socket diagnosis and management, and the systemic factors that impair healing. Diabetes as the most important systemic impairment to healing is a perennial board examination question, as is the distinction between dry socket (not an infection) and post-extraction infection.
Wound Healing Phases
§Phase 1: Haemostasis (Days 0–3)
Haemostasis is the immediate response to tissue injury. Disruption of blood vessels triggers the coagulation cascade and platelet activation simultaneously:
- Vasoconstriction: immediate reflex vasoconstriction (thromboxane A₂, serotonin from platelets) reduces blood flow to the wound
- Platelet adhesion and aggregation: exposed subendothelial collagen (type I and III) and von Willebrand factor (vWF) bind platelet GPIb receptors → platelet adhesion → platelet activation → ADP and thromboxane A₂ release → platelet aggregation → primary platelet plug
- Coagulation cascade: extrinsic pathway activated by tissue factor (TF) released from damaged cells → factor VII → thrombin → fibrinogen converted to fibrin → fibrin mesh reinforces platelet plug → stable clot
- Platelet α-granule release: PDGF (platelet-derived growth factor), TGF-β (transforming growth factor-β), VEGF (vascular endothelial growth factor), EGF (epidermal growth factor) — these growth factors initiate the subsequent phases of wound healing
- The fibrin clot acts as a provisional matrix — scaffold for cell migration and a reservoir of growth factors
Phase 2: Inflammation (Days 0–5)
The inflammatory phase recruits the cellular machinery for debridement and sets up the proliferative phase. The classical signs of inflammation — rubor (redness), calor (heat), dolor (pain), tumor (swelling), and functio laesa (loss of function) — reflect the vascular and cellular events of this phase.
| Cell | Timing | Function | Key Mediators |
|---|---|---|---|
| Neutrophils (PMNs) | Within hours; peak at 24–48h; replaced by day 3–5 | First responders; bacterial phagocytosis; oxidative burst (reactive oxygen species); proteolytic debridement of necrotic tissue; NET formation (neutrophil extracellular traps) | IL-8 (chemotaxis); C5a; LTB₄; CXCL1/2 |
| Macrophages | Day 2–3; dominant from day 3 onward | Orchestrators of wound healing — phagocytosis of bacteria, debris, apoptotic neutrophils; secretion of growth factors; angiogenesis initiation; fibroblast recruitment; matrix metalloproteinase (MMP) release for ECM remodelling | PDGF; TGF-β; FGF; VEGF; IL-1; TNF-α; IL-6 |
| Mast cells | Early inflammation; degranulate rapidly | Vasodilatation (histamine, PGE₂); increased vascular permeability; neutrophil chemotaxis (TNF-α, IL-4, IL-5) | Histamine; PGE₂; PGI₂; tryptase; heparin |
| Lymphocytes (T cells) | Later phase — week 1 onwards | Regulate healing duration; promote transition from proliferation to remodelling; impaired in immunosuppression; T-helper cells co-ordinate adaptive immune response to wound pathogens | IFN-γ (Th1); IL-4, IL-13 (Th2); TGF-β (Treg) |
Phase 3: Proliferation (Days 3–21)
The proliferative phase rebuilds the wound with new tissue — fibroblasts, endothelial cells, and keratinocytes are the primary effectors.
- Fibroplasia: PDGF and TGF-β recruit fibroblasts from surrounding tissue; fibroblasts adhere to fibronectin and collagen in the provisional matrix; fibroblasts synthesise collagen type III (immature — thin fibres, randomly oriented, weaker than type I); they also produce fibronectin, hyaluronic acid, and proteoglycans that form the new extracellular matrix
- Angiogenesis: VEGF (vascular endothelial growth factor — produced by macrophages and keratinocytes) drives sprouting of new capillaries from existing vessels; FGF (fibroblast growth factor) also contributes; new vessels supply oxygen and nutrients to the hypoxic wound environment; pericyte recruitment stabilises new vessels. Granulation tissue is characterised by these new capillaries (giving it its beefy-red appearance) embedded in loose collagen and inflammatory cells
- Epithelialisation: keratinocytes at the wound margin undergo phenotypic change — they retract their tonofilaments, dissolve their hemidesmosomes, and migrate across the moist wound surface by crawling beneath fibrin (thigmotaxis); mitosis of keratinocytes occurs at the edge — NOT at the leading migrating front (contact inhibition of locomotion); the epithelial layer is restored from wound margins inward (for primary healing) or across granulation tissue (for secondary healing); epidermal growth factor (EGF) and KGF (keratinocyte growth factor) drive proliferation
- Wound contraction: from approximately day 5, fibroblasts differentiate into myofibroblasts (expressing α-smooth muscle actin — α-SMA) under TGF-β stimulation; myofibroblasts contain actin-myosin contractile apparatus that contracts, pulling wound margins together; contraction reduces wound surface area and is most significant in wounds healing by secondary intention; excessive myofibroblast persistence leads to fibrosis and contracture
Phase 4: Remodelling / Maturation (Weeks 3 – 2 Years)
During remodelling, the provisional collagen type III matrix is progressively replaced by the stronger, better-organised collagen type I. Matrix metalloproteinases (MMPs — collagenase, gelatinase, stromelysin) secreted by macrophages, fibroblasts, and keratinocytes degrade collagen type III and fibronectin; tissue inhibitors of metalloproteinases (TIMPs) regulate MMP activity. New collagen type I fibres are laid down in the direction of mechanical stress (Wolff’s law adaptation). Scar tensile strength increases progressively: 3 weeks ≈ 20%; 6 weeks ≈ 50–60%; 3 months ≈ 70–80%. Maximum tensile strength of scar: approximately 80% of unwounded tissue — never fully restored. Myofibroblasts undergo apoptosis as remodelling progresses (normal healing); if they persist → fibrosis / keloid.
Types of Wound Closure
§| Type | Definition | Features | Examples in Dentistry |
|---|---|---|---|
| Primary intention (first intention) | Wound edges are approximated and sutured immediately after surgical incision | Minimal tissue gap; minimal granulation tissue formation; rapid epithelialisation (24–48h); minimal scarring; requires clean, non-infected wound and tension-free closure | Extraction socket closure with suture; surgical access flap sutured; implant incision closure; most elective surgical wounds |
| Secondary intention (second intention) | Wound left open to heal from base upward by granulation tissue formation and epithelialisation from wound margins | Large tissue gap; extensive granulation tissue; prolonged healing; more scarring and wound contraction; used when primary closure is not possible (contaminated wounds, tissue loss) | Infected extraction socket (open healing); palatal donor site after free gingival graft; large excision wounds; wounds with significant tissue loss after trauma |
| Tertiary intention (delayed primary closure) | Wound initially left open (contaminated/infected), debrided and managed with dressings, then closed primarily after 4–5 days when bacterial load is reduced and granulation tissue is healthy | Combines initial open management with delayed suture closure; reduces risk of suturing in infected wound; allows adequate debridement; better outcome than leaving to secondary intention in suitable cases | Laceration with significant contamination; abscess cavity debrided then closed when clean; traumatic soft tissue wounds with questionable viability |
Flap Design Principles in Oral Surgery
§A mucoperiosteal flap consists of epithelium, connective tissue, and periosteum elevated as a single full-thickness layer. Correct flap design ensures adequate access, adequate blood supply, and tension-free closure over intact bone.
| Design Principle | Detail and Rationale |
|---|---|
| Base wider than apex | Blood supply enters from the base of the flap via submucosal vessels; if the apex is wider than the base, the arterial supply is insufficient for the distal tissue, causing ischaemia and necrosis. Minimum base-to-apex ratio: 1:1 for mucoperiosteal flaps; 2:1 recommended for safety |
| Releasing incisions over solid bone | Vertical releasing incisions must be placed over intact bone (not over the extraction socket or bone defect) — the bone provides a firm base for suture support and reduces risk of wound dehiscence. Incisions over voids lack support and pull apart |
| Avoid anatomical structures | Mental foramen (anterior to first mandibular premolar, inferior — releasing incisions placed mesial to the canine or distal to the premolars to avoid the mental nerve); greater palatine vessels (palatal flap must not cross the greater palatine foramen carelessly); lingual nerve (reflected away when raising lingual flap in mandible) |
| Full-thickness (mucoperiosteal) elevation | Full-thickness elevation includes the periosteum, protecting it and maintaining it attached to the flap — the periosteum receives its blood supply from the overlying soft tissue; periosteal stripping denudes bone and impairs its blood supply and osteoprogenitor cell pool |
| Adequate access without excessive tension | The flap must provide unobstructed access to the surgical site; excessive retraction causes ischaemia at the margins. If access is inadequate, add a releasing incision rather than forcefully retracting |
| Closure line over intact bone | Suture line should be positioned directly over solid bone — avoids wound breakdown over voids and bone grafts. After bone grafting or implant placement, the incision is designed so that the closure lies over the grafted area with supporting bone around the graft margins |
Common Flap Designs
| Design | Description | Indication |
|---|---|---|
| Envelope flap | Horizontal incision along the gingival margin / crest only; no vertical releasing incisions; flap reflects buccally | Simple extractions; anterior maxillary implants; limited exposure required |
| Triangular flap | Horizontal crestal incision + ONE vertical releasing incision at one end | Moderate access; impacted premolars; periapical surgery; bone grafting; single implant site |
| Trapezoidal / rectangular flap | Horizontal crestal incision + TWO vertical releasing incisions (one at each end) | Maximum exposure; impacted third molars; multiple implants; ridge augmentation; cyst enucleation |
| Semilunar flap | Curved horizontal incision in the attached gingiva, parallel to and below the gingival margin; does not involve the gingival margin | Periapical surgery (apicoectomy) — preserves gingival margin aesthetics; limited access; largely replaced by papilla-based flaps |
| Palatal flap | Full-thickness palatal mucoperiosteum; must preserve greater palatine vessels posteriorly; used for palatal tori removal, hard palate defect repair, palatal implant uncovering | Palatal tori; hard palate access; sinus floor exposure via palatal approach |
Suture Materials
§| Suture Material | Type | Absorption Time | Properties / Indications |
|---|---|---|---|
| Vicryl (polyglactin 910) | Synthetic absorbable; braided | 75% strength at 2 weeks; complete absorption 60–90 days | Most widely used absorbable suture in oral surgery; reliable and predictable; moderate tissue drag (braided); minimal inflammatory reaction; mucosal closure; deep layer closure; 3-0 and 4-0 most common sizes |
| Vicryl Rapide (irradiated) | Synthetic absorbable; braided | 50% strength at 5 days; complete absorption 35–42 days | Fast-absorbing version; used when early suture loss is acceptable (e.g. oral mucosa in children; wounds expected to heal rapidly); no suture removal needed |
| Monocryl (poliglecaprone 25) | Synthetic absorbable; monofilament | 50–60% strength at 1 week; complete absorption 90–120 days | Excellent handling; minimal tissue drag; preferred for skin closure and delicate mucosal closure; smooth surface reduces bacterial harbourage; 4-0 and 5-0 for facial skin |
| PDS (polydioxanone) | Synthetic absorbable; monofilament | 50% strength at 4 weeks; complete absorption 180–210 days | Longest-lasting absorbable; used for deep fascial layers, tendons, closure where prolonged support is needed; more memory (stiff — requires more throws to secure knot) |
| Chromic gut | Natural absorbable; twisted multifilament | 50% strength at 10–14 days; complete absorption 21 days | Chromic tanning extends the life of plain gut; still unpredictable absorption rate; significant inflammatory reaction (macrophage proteolytic digestion); used for socket closure where rapid absorption is desired; cheap |
| Plain gut | Natural absorbable; twisted | 50% strength at 5–7 days; complete absorption 10–14 days | Fastest absorbing; minimal wound support duration; significant inflammation; rarely used in modern oral surgery |
| Silk | Natural non-absorbable (practical); braided | Not absorbed (encapsulated — degrades slowly over years) | Comfortable intraorally; pliable; handles well; minimal knot memory; most commonly used non-absorbable suture for intraoral mucosa by many surgeons; wicks bacteria along braided fibres — increased infection risk if left long-term; remove 7–10 days intraorally |
| Nylon (Ethilon, Prolene) | Synthetic non-absorbable; monofilament | Not absorbed | Minimal tissue reactivity; used for facial skin closure (4-0 for face); monofilament = no wicking; stiff — significant memory; remove 5–7 days on face (to prevent suture marks) |
| PTFE (Gore-Tex) | Synthetic non-absorbable; monofilament / expanded | Not absorbed | Minimal tissue reaction; used in guided bone regeneration (GBR) membranes and closure over GBR/GTR sites; very low bacterial adherence; remove 4–6 weeks |
| Stainless steel wire | Synthetic non-absorbable; monofilament | Not absorbed | Extremely strong; no tissue reaction; used for sternotomy closure; orthognathic surgery interdental wiring (IMF); bony fixation; not used for routine soft tissue closure due to difficulty handling |
Wound Closure Principles
§- Tension-free closure: the single most important principle — wound edges must approximate without tension; tension causes ischaemia of wound margins, delayed epithelialisation, suture cut-through, and dehiscence; achieve by adequate flap mobilisation (periosteal scoring releases the elastic periosteal membrane and allows advancement of the flap), releasing incisions, and appropriate flap design
- Layered closure: close deep layers first (submucosa, muscle) with absorbable sutures to eliminate dead space, reduce tension on the superficial layer, and restore tissue planes; dead space = space between tissue layers where blood and serum collect → haematoma → infection risk
- Wound eversion: for skin closure, sutures should slightly evert (roll outward) the wound edges — this counteracts the tendency of skin to invert during scar contraction; everted wound edges produce a flat, less visible scar; inverted edges produce a depressed, more prominent scar
- Haemostasis before closure: all bleeding must be controlled before wound closure — closure over active bleeding creates haematoma; achieve with diathermy (electrosurgery), bone wax, haemostatic agents (Surgicel, Gelfoam), pressure, or sutures
- Preservation of blood supply: avoid unnecessary stripping of periosteum; preserve the submucosal vascular plexus; avoid crushing tissue with heavy retractors; minimise trauma to flap margins with instruments
- Appropriate suture placement: sutures placed 3–5mm from wound edge (oral mucosa) or 2–3mm from wound edge (facial skin); suture spacing 4–8mm apart (oral mucosa) or 3–5mm apart (skin); do not tie so tightly that sutures cut through tissue
Factors Impairing Wound Healing
§Systemic Factors
| Factor | Mechanism of Impairment | Clinical Management |
|---|---|---|
| Diabetes mellitus (#1) | Impaired neutrophil and macrophage function; reduced VEGF and angiogenesis; impaired fibroblast collagen synthesis; collagen glycation (AGEs); peripheral neuropathy masks wound injury; hyperglycaemia promotes bacterial growth | HbA1c <8.0% before elective surgery (ideally <7.0%); morning appointments; glucose monitoring; antibiotic prophylaxis for complex procedures |
| Malnutrition | Vitamin C deficiency (scurvy): impairs hydroxylation of proline and lysine (cofactor for prolyl hydroxylase and lysyl hydroxylase) → unstable, soluble collagen → fragile capillaries, impaired wound healing; Zinc deficiency: impairs fibroblast proliferation and DNA synthesis → impaired proliferative phase; Protein deficiency: inadequate amino acid substrate for collagen and enzyme synthesis | Nutritional assessment; vitamin C supplementation perioperatively; correct zinc deficiency; dietitian referral for severe malnutrition |
| Corticosteroids | Suppress inflammation (reduces macrophage activity → impaired growth factor release); impair fibroblast proliferation and collagen synthesis; increase susceptibility to infection; reduce scar tensile strength | Consider steroid cover in HPA-suppressed patients; liaise with physician; minimise steroid dose perioperatively where possible; be vigilant for wound infection |
| Smoking | Vasoconstriction (nicotine — reduces mucosal blood flow); carbon monoxide reduces O₂-carrying capacity of haemoglobin; impairs neutrophil migration and phagocytosis; nicotine inhibits fibroblast proliferation; continine (smoking metabolite) impairs angiogenesis; sucking motion dislodges oral wound clots | Advise cessation ≥48h pre-op and ≥2 weeks post-op (minimum); warn of increased dry socket risk; chlorhexidine mouthwash as adjunct |
| Radiotherapy | Obliterative endarteritis (progressively occlusive vascular fibrosis at the irradiated tissue microvasculature) → hypoxic, hypocellular, hypovascular (3H) tissue; impairs all phases; increases risk of MRONJ in irradiated jaw bone; effects are permanent and cumulative; risk dose >50Gy to jaw | Hyperbaric oxygen (HBO) therapy pre- and post-operatively for extractions in irradiated fields; liaise with oncologist; use atraumatic technique; delay elective procedures where possible; consider MRONJ risk |
| Chemotherapy | Myelosuppression → neutropenia (increased infection risk; neutrophil count <1.0×10⁹/L = profound neutropenia); impaired rapidly dividing cells → impaired epithelialisation, fibroblast proliferation; thrombocytopenia (platelet count <50×10⁹/L = increased bleeding risk) | Liaise with oncologist; time dental procedures between chemotherapy cycles when counts are highest; check FBC pre-op; antibiotic prophylaxis; avoid elective procedures when neutropenic |
| Renal failure / uraemia | Uraemia impairs platelet function (platelet–vessel wall interaction); impairs collagen synthesis; accumulation of uraemic toxins impairs fibroblast function; patients often anaemic (reduced EPO) | Check renal function pre-op; liaise with nephrologist; platelet function tests; DDAVP may improve platelet function in uraemic patients; timing relative to dialysis |
| Hepatic failure | Impaired synthesis of clotting factors (II, VII, IX, X — vitamin K-dependent; fibrinogen); hypersplenism → thrombocytopenia; impaired drug metabolism (accumulation of anaesthetic/analgesic agents) | Check LFTs, PT/INR, platelet count, albumin; liaise with hepatologist; fresh frozen plasma (FFP) or platelet transfusion as needed; vitamin K supplementation; minimise hepatotoxic drugs |
Local Factors Impairing Wound Healing
- Wound infection: bacterial proteases digest collagen and fibrin; neutrophil oxidative burst in response to bacteria also damages surrounding tissue; biofilm formation resists host defences; delayed healing and increased dehiscence
- Haematoma: blood collection creates dead space; medium for bacterial growth; separates wound edges; impairs oxygen diffusion; must be evacuated if large
- Dead space: space between tissue layers where serum and blood accumulate; supports bacterial growth; prevent by layered closure and drain insertion for large cavities
- Wound tension: excessive tension causes wound edge ischaemia; tissue necrosis at margins; suture cut-through; dehiscence; pain
- Foreign body: retained suture material, bone fragments, dental materials → chronic inflammatory reaction → impaired healing; foreign body granuloma
- Movement / trauma: excessive movement of wound edges prevents collagen fibril alignment and epithelialisation; jaw movements disrupt intraoral wound edges — advise soft diet and jaw rest
- Poor blood supply: peripheral vascular disease; radiation; local compression from excessive retraction or tight sutures; ischaemic wound edges → necrosis
Wound Complications
§Wound Infection
Post-surgical wound infection presents with the classic signs of inflammation plus purulent discharge. In oral surgery, wound infections typically present 3–7 days post-operatively. Diagnosis: erythema, oedema, warmth, pain, purulent exudate ± fever ± regional lymphadenopathy.
Management: if fluctuant (fluctuant = pus collection = abscess) → incision and drainage (I&D) is the primary treatment — antibiotics cannot penetrate a walled-off abscess; if spreading cellulitis (indurated, non-fluctuant, no pus) → antibiotics (amoxicillin 500mg TDS or co-amoxiclav 625mg TDS for 5–7 days; metronidazole 400mg TDS added for anaerobic cover or penicillin-allergic patients); if systemic signs (fever, trismus, dysphagia, difficulty breathing, Ludwig’s angina, raised WBC >12) → hospital admission, IV antibiotics, surgical drainage.
Dry Socket (Alveolar Osteitis)
Dry socket is the most common post-extraction complication (2–5% of all extractions; 20–30% of mandibular third molar extractions). It is caused by premature loss or failure of formation of the blood clot in the extraction socket.
| Feature | Dry Socket (Alveolar Osteitis) | Post-extraction Infection |
|---|---|---|
| Onset | Days 2–4 post-extraction | Days 3–7 post-extraction |
| Pain | Severe, continuous, throbbing, radiating to ear/temple — out of proportion | Throbbing, localised; may be less severe than dry socket initially |
| Socket appearance | Empty socket — absent or degenerated clot; bare bone visible; food debris; halitosis | Socket may contain blood/clot but surrounded by erythematous swollen tissues; pus from socket or adjacent gingiva; fluctuance if abscess |
| Swelling/erythema | Minimal or absent (no infection) | Present — erythema, oedema, warmth, possible fluctuance |
| Fever / systemic symptoms | Absent | May be present (fever, malaise, raised WBC) |
| Lymphadenopathy | Absent or minimal | Present (regional lymphadenopathy) |
| Management | Irrigation + ZOE dressing (Alvogyl) + analgesics. NO antibiotics (unless osteomyelitis develops) | I&D if fluctuant; antibiotics (amoxicillin ± metronidazole) if cellulitis; hospital admission if severe/spreading |
Wound Dehiscence
Dehiscence is separation of wound edges, most commonly occurring after suture removal (premature removal) or if sutured under excessive tension. In oral surgery, partial dehiscence is common and usually heals by secondary intention without intervention. Complete dehiscence exposing underlying surgical site (implant, graft) requires management.
Management: minor dehiscence — irrigate with 0.2% chlorhexidine; leave to secondary healing; advise patient to keep area clean; monitor weekly. Major dehiscence over implant/graft — if implant/graft exposed: may require membrane / graft removal and delayed re-implantation; systemic antibiotics; maintain hygiene; consider re-suturing if wound is clean and granulation tissue healthy (tertiary intention).
Haematoma
Haematoma is a collection of blood in the wound caused by inadequate haemostasis or disruption of blood vessels post-closure. Risk factors: anticoagulants (warfarin, DOACs, aspirin); hypertension; traumatic dissection; inadequate pressure post-operatively. Features: swelling, tense, tender, purple/blue discolouration; may cause trismus or airway compromise if large.
Management: small haematoma — conservative (pressure dressing; monitor for resolution over 2–3 weeks); large or expanding haematoma — open wound, evacuate clot, identify and ligate bleeding vessel, replace drainage; haematoma in floor of mouth or neck — urgent assessment (may compromise airway).
Abnormal Scarring — Keloid vs Hypertrophic Scar
| Feature | Hypertrophic Scar | Keloid |
|---|---|---|
| Definition | Raised, red scar that stays WITHIN the original wound margins | Raised, red scar that EXTENDS BEYOND the original wound margins (invades surrounding normal tissue) |
| Timing | Develops within weeks; may regress over months–years | Develops months after injury; does NOT regress spontaneously |
| Sites | High-tension areas: chest, shoulder, over joints | Earlobes, sternum, deltoid, chin, jawline; any site in susceptible individuals |
| Histology | Excess collagen III; nodular arrangement; myofibroblasts persist | Excess collagen I (thick, haphazardly arranged, keloidal collagen); absence of myofibroblasts in mature keloid |
| Risk factors | Wound tension; infection; dehiscence; specific anatomical sites | Genetic predisposition (autosomal dominant — incomplete penetrance); darker skin types; young adults; specific anatomical sites |
| Treatment | Intralesional triamcinolone acetonide (10–40mg/mL injections); pressure therapy; silicone gel sheets; laser (pulsed dye laser); surgical revision (with adjuvant triamcinolone) | Intralesional triamcinolone; pressure therapy; silicone gel; radiotherapy post-excision (reduces recurrence); surgical excision + post-op radiotherapy; 5-FU; interferon; high recurrence rate after surgery alone |
Post-operative Instructions and Wound Care
§| Instruction | Rationale | Detail |
|---|---|---|
| No rinsing for 24 hours | Allows blood clot to stabilise in socket; rinsing dislodges clot → dry socket risk | After 24h: gentle rinsing with warm saline (dissolved teaspoon salt in warm water TDS) or 0.2% chlorhexidine gluconate mouthwash BD for 1–2 weeks |
| Bite on gauze | Pressure promotes haemostasis; compresses socket walls against clot | Bite firmly on gauze pack for 30–45 min post-extraction; replace if soaked; avoid chewing on gauze |
| Soft diet | Reduces mechanical trauma to wound and sutures; prevents dislodgement of clot | Soft foods only for 48–72h; avoid hot foods/drinks (vasodilate mucosal vessels → bleeding); avoid hard, chewy foods for 1 week; small bite sizes |
| No smoking | Vasoconstriction impairs healing; sucking action dislodges clot; cotinine impairs neutrophil function | Minimum 48h post-extraction; ideally 2 weeks; warn of significantly increased dry socket risk |
| No straws / suction | Negative intraoral pressure dislodges blood clot | Avoid for 48–72h post-extraction |
| Analgesia | Post-operative pain management; anti-inflammatory effect (NSAIDs) | Ibuprofen 400–600mg TDS with food (with paracetamol 1g QDS for multimodal analgesia); take first dose before local anaesthetic wears off; codeine phosphate 30mg QDS if inadequate with NSAIDs + paracetamol (short course) |
| Ice packs | Reduce post-operative swelling (oedema) by vasoconstriction | Apply ice pack (wrapped in cloth — not direct skin contact) to face for 20 min on / 20 min off for first 24h; after 24h switch to warm compresses to promote resolution |
| Oral hygiene maintenance | Reduces bacterial load in oral cavity; reduces post-operative infection risk | Resume brushing remaining teeth from same evening (gently); avoid toothbrush contact with surgical site for 48h; chlorhexidine 0.2% mouthwash from day 2 (do not use for more than 2 weeks continuously due to staining) |
| Warning signs to report | Early recognition of complications | Increasing pain after day 3 (dry socket); swelling increasing after 48h (infection); uncontrolled bleeding; difficulty swallowing or breathing (Ludwig’s angina); numbness persisting beyond expected anaesthetic duration (nerve injury); fever >38°C |
Clinical Considerations
§- Vitamin C is essential for collagen synthesis — deficiency (scurvy) causes impaired wound healing, fragile capillaries, and gingival haemorrhage: Vitamin C (ascorbic acid) is an essential cofactor for prolyl hydroxylase and lysyl hydroxylase — the enzymes that hydroxylate proline and lysine residues in procollagen chains. Hydroxylation is required for stable triple-helix formation and subsequent cross-linking of collagen fibres. Without vitamin C, procollagen cannot form stable triple helices — the resulting collagen is soluble and weak. Clinically, scurvy presents with: perifollicular haemorrhages (corkscrew hairs); gingival swelling, bleeding, and infection (periodontitis-like appearance in severe scurvy — “scurvy gum”); impaired wound healing; poor bone repair; petechiae and bruising. Dentists may encounter vitamin C deficiency in elderly patients, alcoholics, and those with very restricted diets. Perioperative vitamin C supplementation (500mg daily) is reasonable in patients with suspected deficiency.
- Zinc is required for fibroblast proliferation and DNA synthesis — zinc deficiency impairs the proliferative phase of wound healing: Zinc is a cofactor for over 300 enzymes, including DNA polymerase and RNA polymerase — both essential for cell division. Fibroblast proliferation during the proliferative phase requires rapid DNA synthesis and cell division; zinc deficiency significantly impairs this. Zinc is also required for collagen cross-linking (cofactor for lysyl oxidase) and for vitamin A metabolism (required for epithelialisation). Clinical signs of zinc deficiency: acrodermatitis enteropathica (perioral/perianal rash); impaired taste and smell; delayed wound healing; alopecia; hypogonadism. Risk groups: patients with Crohn’s disease, celiac disease, excessive alcohol intake, parenteral nutrition without zinc supplementation, and patients on diuretics (increased renal zinc excretion).
- The distinction between dry socket (alveolar osteitis) and post-extraction infection is critical — they have different management: Dry socket: days 2–4; empty socket with bare bone; severe radiating pain; no fever, no pus, no swelling; management = ZOE dressing + analgesics (NO antibiotics). Post-extraction infection: days 3–7; socket surrounded by erythematous, oedematous tissue; possible pus or fluctuance; ± fever and lymphadenopathy; management = incision and drainage (if fluctuant) + antibiotics. The most common error is prescribing antibiotics for dry socket — this does not treat the underlying pathology (absence of clot) and merely adds antibiotic side effects and resistance risk.
- Suture removal timing is tissue-specific — facial skin sutures must be removed at 5–7 days to prevent epithelial suture track marks (“railroad tracks”): Suture marks (suture track marks / “railroad tracks”) form when epithelium grows down into the suture channel alongside the suture material — this occurs after approximately 7 days. If sutures are left longer, the epithelial channels become permanent scars perpendicular to the wound axis, creating a characteristic rail-track scar pattern that may be permanent. Removal timing guidelines: facial skin — 5–7 days; oral mucosa (non-absorbable) — 7–10 days; eyelid — 3–5 days; scalp — 7–10 days; extremity/joint area — 10–14 days; back/abdominal/chest wall — 10–14 days. Absorbable sutures in the oral cavity (Vicryl, Vicryl Rapide, chromic gut) do not need removal — they dissolve or are cleared by the patient.
- Periosteal scoring (periosteal release) is the technique used to advance a flap for tension-free closure — it divides the elastic periosteal layer to allow the flap to advance without stretching the overlying mucosa: When a surgical flap cannot be closed without tension, the periosteum is the limiting elastic layer. Periosteal scoring involves making multiple shallow horizontal cuts through the periosteum (not the full thickness of the flap) at the base of the flap using a scalpel blade. Each cut releases the elasticity of the periosteum and allows additional advancement of the flap (typically 2–4mm per score line). This is particularly important when closing flaps over bone grafts, guided bone regeneration (GBR) membranes, or dental implants in areas with deficient bone volume. The periosteal scoring must be done carefully to avoid cutting through the full flap thickness and entering the submucosal space — the blood vessels supplying the flap run within the submucosal layer.
Common Mistakes to Avoid
§| # | Misconception | Correction |
|---|---|---|
| 1 | “Dry socket is an infection and should be treated with antibiotics.” | Alveolar osteitis (dry socket) is NOT a primary bacterial infection — it is a failure of clot organisation or clot loss leading to bare bone exposure. Antibiotics do NOT treat the underlying pathology, do not speed healing, and are NOT indicated for uncomplicated dry socket. Management is: gentle socket irrigation + ZOE (eugenol-based) dressing + analgesics. Antibiotics are only added if signs of osteomyelitis develop (persistent spreading infection with constitutional symptoms beyond 2–3 weeks). |
| 2 | “Wound healing produces scar tissue that eventually becomes as strong as normal tissue.” | Scar tissue NEVER achieves the same tensile strength as unwounded tissue. The maximum tensile strength of a mature scar is approximately 80% of the original unwounded tissue. This is because scar collagen fibres (type I) are organised in a more random orientation compared to the highly organised, crimped pattern of normal dermal collagen — the random orientation is less efficient at resisting tensile forces. Patients should be advised that healed wounds have permanently reduced strength. |
| 3 | “Neutrophils are the most important cells throughout the healing process.” | Neutrophils are important in the early inflammatory phase (debridement and bactericidal functions) but are replaced by macrophages from day 2–3. Macrophages are the true orchestrators of wound healing — they phagocytose debris, apoptotic neutrophils, and bacteria, AND secrete the growth factors (PDGF, TGF-β, VEGF, FGF) that drive the proliferative phase. Wounds depleted of macrophages (but not neutrophils) fail to heal properly — neutrophil depletion produces some impairment; macrophage depletion produces catastrophic healing failure in experimental models. |
| 4 | “The flap releasing incision should be placed directly over the extraction socket for maximum access.” | Releasing incisions should NEVER be placed over the surgical defect (extraction socket, bone graft, implant site) — the suture line must be over intact bone. Placing the incision over the void means: (1) the wound has no bony support beneath it and is under traction from the underlying cavity; (2) dehiscence is far more likely; (3) if dehiscence occurs, the underlying implant/graft is immediately exposed to oral contamination. The releasing incision should be placed over intact bone, away from the margins of the surgical defect. |
| 5 | “Collagen type I is produced first during wound healing and then replaced by type III.” | This is the opposite of what occurs. During the proliferative phase, fibroblasts initially produce predominantly collagen type III (thin, randomly arranged fibres — the provisional scar). During the remodelling phase, collagen type III is progressively replaced by collagen type I (thicker, better cross-linked, stronger, organised along lines of stress). This switch from type III to type I is mediated by matrix metalloproteinases (MMPs) degrading type III and new type I synthesis by fibroblasts under mechanical stimulation. The final scar is predominantly type I collagen, which is why it is stiffer and stronger than the initial granulation tissue. |
Related Topics
§References
§- Singer AJ, Clark RAF. Cutaneous wound healing. N Engl J Med. 1999;341(10):738–746.
- Guo S, DiPietro LA. Factors affecting wound healing. J Dent Res. 2010;89(3):219–229.
- Blondeau JM, Segura A, Bhatt M. Oral surgery wound management: Evidence-based recommendations for antibiotic prophylaxis and post-operative care. J Can Dent Assoc. 2012;78:c52.
- Torres-Lagares D, Serrera-Figallo MA, Romero-Ruíz MM, Infante-Cossío P, García-Calderón M, Gutierrez-Perez JL. Update on dry socket: a review of the literature. Med Oral Patol Oral Cir Bucal. 2005;10(1):81–85.
- Nusair YM, Younis MHA. Prevalence, clinical picture, and risk factors of dry socket in a Jordanian dental teaching center. J Contemp Dent Pract. 2007;8(3):53–63.
- Miloro M, Ghali GE, Larsen P, Waite P, eds. Peterson’s Principles of Oral and Maxillofacial Surgery. 3rd ed. Shelton, CT: PMPH-USA; 2012. Chapters 1–3 (wound healing and wound closure).
- Hupp JR, Ellis E III, Tucker MR. Contemporary Oral and Maxillofacial Surgery. 7th ed. St Louis: Elsevier; 2019. Chapters 8–11.
- Mubarak YA. Prevalence of alveolar osteitis (dry socket) following molar teeth extractions. J Oral Maxillofac Surg. 2016;15(4):155–160.
Summary
§Wound healing proceeds through four overlapping phases — haemostasis (platelet fibrin clot formation), inflammation (neutrophils then macrophages debride and signal), proliferation (fibroblasts produce collagen type III, angiogenesis, epithelialisation), and remodelling (collagen III replaced by type I; maximum 80% tensile strength of unwounded tissue). Dry socket (alveolar osteitis) is the most common post-extraction complication — it is NOT an infection, and antibiotics are NOT indicated; management is socket irrigation plus ZOE dressing. Suture selection follows the principle of matching absorption time to the duration of wound support required — Vicryl is the most widely used oral surgery suture. Flap design must always maintain a wider base than apex, place releasing incisions over intact bone, and avoid anatomical structures including the mental foramen. Diabetes mellitus is the most clinically significant systemic impairment to wound healing, acting through neutrophil dysfunction, impaired angiogenesis, impaired collagen synthesis, and increased infection susceptibility.
High-Yield Summary — INBDE / NBDE Board Review
- Phase sequence: Haemostasis → Inflammation (PMNs first, then macrophages) → Proliferation (collagen III, angiogenesis, epithelialisation) → Remodelling (collagen I, max 80% tensile strength)
- Macrophages: orchestrators of wound healing — secrete PDGF, TGF-β, VEGF, FGF to drive proliferation; more important than neutrophils for overall healing
- Dry socket: days 2–4; NOT infection; NO antibiotics; ZOE dressing + analgesics; risk factors: smoking (#1), OCP, third molar extractions
- Vitamin C: cofactor for prolyl/lysyl hydroxylase → collagen triple helix formation; deficiency (scurvy) = fragile capillaries, gingival bleeding, impaired healing
- Diabetes mellitus: #1 systemic impairment — neutrophil/macrophage dysfunction + impaired angiogenesis + reduced collagen synthesis + infection risk; HbA1c <8.0% before elective surgery
- Flap rule: base wider than apex; releasing incisions over intact bone; avoid mental foramen; full-thickness elevation preserves periosteum
- Sutures: Vicryl (most common oral surgery, absorbable, 60–90 days); Monocryl (skin, absorbable, 90–120 days); Silk (comfortable intraorally, remove 7–10 days); Nylon (facial skin, remove 5–7 days)
- Collagen type sequence: proliferation = type III (provisional scar); remodelling = type I replaces type III (mature, stronger scar)
- Keloid vs hypertrophic: keloid extends BEYOND wound margins, does not regress, darker skin types; hypertrophic stays WITHIN wound margins, may regress; both treated with intralesional triamcinolone
- Periosteal scoring: releases elastic periosteum to allow tension-free flap advancement for closure over bone grafts/implants; horizontal cuts through periosteum at flap base

